ESC 2024: CATHEDRAL-HF trial results have the potential to reduce polypharmacy
A large proportion of chronic heart failure (HF) patients are taking suboptimal doses of relevant medications.
A large proportion of chronic heart failure (HF) patients are taking suboptimal doses of relevant medications.
What's Your Reaction?
